213 results on '"Uraki, Ryuta"'
Search Results
2. In vitro and in vivo characterization of SARS-CoV-2 resistance to ensitrelvir
3. Antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination
4. Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates
5. Plasminogen activator inhibitor 1 is not a major causative factor for exacerbation in a mouse model of SARS-CoV-2 infection
6. Antiviral efficacy against and replicative fitness of an XBB.1.9.1 clinical isolate
7. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents
8. Transmission and re-infection of Omicron variant XBB.1.5 in hamsters
9. In SARS-CoV-2 delta variants, Spike-P681R and D950N promote membrane fusion, Spike-P681R enhances spike cleavage, but neither substitution affects pathogenicity in hamsters
10. Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV-2 Omicron BA.1 in Syrian hamsters
11. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
12. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
13. REPLY TO SLOMINSKI ET AL. : UVB irradiation induces proenkephalin⁺ regulatory T cells with a wound-healing function
14. Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters
15. Proenkephalin⁺ regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function
16. An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicron variants
17. Airway surveillance and lung viral control by memory T cells induced by COVID-19 mRNA vaccine
18. Loss of the TAM Receptor Axl Ameliorates Severe Zika Virus Pathogenesis and Reduces Apoptosis in Microglia
19. Host glycolipids in SARS-CoV-2 entry
20. Differences in the ease with which mutant viruses escape from human monoclonal antibodies against the HA stem of influenza A virus
21. Characterization of an EG.5.1 clinical isolate in vitro and in vivo
22. Aedes aegypti AgBR1 antibodies modulate early Zika virus infection of mice
23. Emergence of Oseltamivir-Resistant H7N9 Influenza Viruses in Immunosuppressed Cynomolgus Macaques
24. Fetal Growth Restriction Caused by Sexual Transmission of Zika Virus in Mice
25. In vitro and in vivo characterization of SARS-CoV-2 strains resistant to nirmatrelvir
26. Efficacy of antivirals and mRNA vaccination against an XBF clinical isolate
27. Evaluation of seasonal influenza vaccines for H1N1pdm09 and type B viruses based on a replication-incompetent PB2-KO virus
28. Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivo
29. Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate
30. Oral intake of heat-killed Lactiplantibacillus pentosus ONRICb0240 partially protects mice against SARS-CoV-2 infection
31. Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1
32. A Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice From Secondary Pneumococcal Pneumonia
33. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
34. AgBR1 antibodies delay lethal Aedes aegypti-borne West Nile virus infection in mice
35. Mature dendritic cells enriched in regulatory molecules may control regulatory T cells and the prognosis of head and neck cancer
36. Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB
37. Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB
38. In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6
39. Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75
40. Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates
41. Hemozoin as a novel adjuvant for inactivated whole virion influenza vaccine
42. Research article antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination.
43. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 clinical isolates
44. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2
45. Therapeutic efficacy of antibodies and antivirals against a SARS-CoV-2 Omicron variant
46. The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters
47. Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens
48. Host glycolipids in SARS-CoV-2 entry
49. Basic Research Reveals the Unique Virologic Features of SARS-CoV-2
50. Characterization of H7N9 influenza A viruses isolated from humans
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.